Prognostic Value of Variant Histology in Upper Tract Urothelial Carcinoma Treated with Nephroureterectomy: A Systematic Review and Meta-Analysis.
This systematic review and meta-analysis aimed to assess the prognostic value of variant histology in patients with upper tract urothelial carcinoma (UTUC) treated with radical nephroureterectomy. The PUBMED, Web of Science, Cochrane Library, and Scopus databases were searched in May 2019 according to the Preferred Reporting Items for Systematic Review and Meta-analysis (PRISMA) statement. Studies were deemed eligible if they compared overall, cancer-specific, and recurrence-free survival in UTUC patients with and without variant histology. Formal meta-analyses were performed for these outcomes. The review identified 32 studies with 16,052 patients, including 26 studies and 12,865 patients that were eligible for the meta-analysis. Variant histology was associated with poor outcomes in terms of cancer-specific survival (pooled hazard ratio [HR]: 2.00, 95% confidence interval [CI]: 1.57-2.56), overall survival (pooled HR: 1.76, 95% CI: 1.51-2.04), and recurrence-free survival (pooled HR: 1.64, 95% CI: 1.42-1.89). Subgroup analyses revealed that 'micropapillary' and 'squamous and/or glandular' variant histology were also associated with poor cancer-specific survival (pooled HR: 3.02, 95% CI: 1.71-5.34, and pooled HR: 1.48, 95% CI: 1.14-1.92, respectively). Variant histology in patients with UTUC is associated with an increased risk of cancer-specific mortality, overall mortality, and disease recurrence. Furthermore, variant histology was independently associated with cancer-specific survival in the 'micropapillary' and 'squamous and/or glandular' variant histology subgroups. It might be useful to incorporate variant histology into prognostic tools that help guide patients and physicians in selecting appropriate treatment strategies for UTUC.